Internal medicine (Tokyo, Japan) · 2020
Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Masuda Sakue, Koizumi Kazuya, Moriya Hidekazu, Nishino Takashi, Uojima Haruki, Tazawa Tomohiko, Kimura Karen, Tasaki Junichi, Ichita Chikamasa, Sasaki Akiko, Kako Makoto, Hidaka Sumi, Kudo Madoka
Аннотация
We herein describe an 82-year-old patient who presented with proteinuria and systemic edema. He was diagnosed with minimal change disease (MCD) and was found to have stage III pancreatic cancer. He could not undergo surgical resection due to invasion to the celiac artery and he was thus treated with chemotherapy. After a month of chemotherapy, his proteinuria improved to a normal level. After two months of chemotherapy, computed tomography indicated a partial response to the therapy. MCD can occur as paraneoplastic syndrome in patients with malignant disease, and chemotherapy can be effective for MCD associated with paraneoplastic syndrome.